SPC181

Deoxýkólínsýru-natríumsalt

  • Status:
    Veitt
  • Application date:
    24.1.2017
  • Application published:
    15.2.2017
  • Grant published:
    15.9.2022
  • Max expiry date:
    7.2.2030
  • Next due date:
    28.2.2027
  • Medicine name:
    Belkyra
  • Medicine for children:
    No

Timeline

Today
24.1.2017Application
15.2.2017Publication
15.9.2022Registration
7.2.2027Expires

Marketing license

  • IS authorization number:
    IS/1/16/071/01
  • Date:
    29.7.2016

    Owner

    • Name:
      Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
    • Address:
      1124 West Carson Street, Torrance US
    • Name:
      The Regents of the University of California
    • Address:
      1111 Franklin Street, 12th Floor, Oakland, CA US

    Agent

    • Name:
      Árnason Faktor ehf.
    • Address:
      Guðríðarstíg 2-4, 113 Reykjavík

    Patent

    Annual fees

    Number

    Paid

    Expires

    Payer

    Number: 1

    Paid: 27.12.2024

    Expires: 7.2.2026

    Payer: Árnason Faktor ehf.

    Number: 2

    Paid: 12.1.2026

    Expires: 7.2.2027

    Payer: Árnason Faktor ehf.

    Upload documents